Avoro Capital Advisors - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2010
Avoro Capital Advisors is a global venture capital firm specializing in life sciences and biotechnology startups. The firm invests in publicly traded, early, and late-stage companies, focusing on scientific breakthroughs that address unmet medical needs. Avoro typically participates in various investment rounds, including Series B, Series C, and post-IPO equity, providing both financial and intellectual support throughout the investment lifecycle.
Notable portfolio companies include Aadi Bioscience, Allogene Therapeutics, Krystal Biotech, Kymera Therapeutics, Mersana Therapeutics, Scribe Therapeutics, Tango Therapeutics, and Vividion Therapeutics. Avoro's investment philosophy emphasizes identifying unique or mispriced opportunities and managing macro and company-specific risks. The firm offers a comprehensive approach to dissecting complex situations, aiming to provide substantial value-add services to its portfolio companies.
Avoro Capital Advisors - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
